MedPath

Yonsei University

Yonsei University logo
🇰🇷South Korea
Ownership
Private
Established
1885-01-01
Employees
5K
Market Cap
-
Website
http://www.yonsei.ac.kr

Effects of Statin on Hepatocellular Carcinoma Recurrence After Liver Transplantation

Completed
Conditions
Hepatocellular Carcinoma
Interventions
Drug: Statin
First Posted Date
2018-04-06
Last Posted Date
2018-04-06
Lead Sponsor
Yonsei University
Target Recruit Count
350
Registration Number
NCT03490461
Locations
🇰🇷

Division of Endocrinology and Metabolism Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of

Rivaroxaban Once Daily Versus Dose-adjusted Vitamin K Antagonist on the Biomarkers in Acute Decompensated Heart Failure and Atrial Fibrillation (ROAD HF-AF)

Phase 4
Conditions
Acute Heart Failure
Interventions
First Posted Date
2018-04-06
Last Posted Date
2019-01-10
Lead Sponsor
Yonsei University
Target Recruit Count
150
Registration Number
NCT03490994
Locations
🇰🇷

Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of

A Study for Identification of Predictive Immune Biomarker in Peripheral Blood for Nivolumab Therapy in NSCLC Patients

Completed
Conditions
Non -Small Cell Lung Cancer
First Posted Date
2018-04-03
Last Posted Date
2020-10-19
Lead Sponsor
Yonsei University
Target Recruit Count
60
Registration Number
NCT03486119
Locations
🇰🇷

Department of Oncology, Yonsei University College of Medicine, Seoul, Korea, Korea, Republic of

Assessment and Prediction of Cetuximab-Induced Hypersensitivity Reactions Using Cetuximab Specific IgE Detection

Conditions
Tumor Disease Including Colorectal Cancer
Head & Neck Squamous Cell Carcinoma
First Posted Date
2018-04-02
Last Posted Date
2019-04-02
Lead Sponsor
Yonsei University
Target Recruit Count
400
Registration Number
NCT03485638
Locations
🇰🇷

Division of Allergy and Immunology, Department of Internal Medicine, Yonsei University, Seoul, Korea, Republic of

Prediction of Benefit From Adjuvant Chemotherapy for pT1N1 Gastric Cancer

Conditions
Gastric Cancer
First Posted Date
2018-04-02
Last Posted Date
2018-04-09
Lead Sponsor
Yonsei University
Target Recruit Count
1000
Registration Number
NCT03485105
Locations
🇰🇷

Division of Upper Gastrointestinal Surgery, Department of Surgery, Yonsei University College of Medicine, Seoul, Korea, Republic of

Effect of Immunosuppression in IgA Nephropathy

Phase 4
Conditions
Biopsy-proven IgA Nephropathy
Interventions
Drug: Immunosuppressive treatment
Other: intensive supportive care
First Posted Date
2018-03-19
Last Posted Date
2019-02-08
Lead Sponsor
Yonsei University
Target Recruit Count
174
Registration Number
NCT03468972
Locations
🇰🇷

Severance Hospital, Seoul, Korea, Republic of

Comparison of Propofol Requirement Between Patients With Pituitary Somatotroph Tumor and With Nonfunctioning Pituitary Tumor in Transsphenoidal Pituitary Surgery Under Total Intravenous Anesthesia

Completed
Conditions
Pituitary Tumor
Interventions
Procedure: Not applicable (measuring subject's effect site concentration of propofol during the induction of general anesthesia)
First Posted Date
2018-03-14
Last Posted Date
2019-02-08
Lead Sponsor
Yonsei University
Target Recruit Count
62
Registration Number
NCT03465423
Locations
🇰🇷

Associate Professor Department of Anesthesiology and Pain Medicine, Seoul, Korea, Republic of

The Effects of Optimizing Post-operative Pain Management With Multi Modal Analgesia on Immune Suppression and Oncologic Outcome in Patients Undergoing Laparoscopic Colorectal Surgery

Not Applicable
Withdrawn
Conditions
Laparoscopic Colorectal Resection Due to Cancer
Interventions
Drug: IV ketamine/lidocaine/IV PCA apply
Drug: IV PCA only apply
First Posted Date
2018-03-13
Last Posted Date
2019-07-08
Lead Sponsor
Yonsei University
Registration Number
NCT03462836
Locations
🇰🇷

Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea, Seoul, Korea, Republic of

Comparison of Ability of pCLE and WLE for Diagnosis and Cancer Tissue Acquisition in Advanced Gastric Cancer After Chemotherapy Status

Not Applicable
Conditions
Palliative Chemotherapy
Advanced Gastric Cancer
Neoadjuvant Chemotherapy
Interventions
Device: Confocal group
Device: Control group
First Posted Date
2018-02-28
Last Posted Date
2019-01-11
Lead Sponsor
Yonsei University
Target Recruit Count
55
Registration Number
NCT03449966
Locations
🇰🇷

Yonsei university of medical center, Seoul, Korea, Republic of

Comparison Between Volatile Anesthetic-desflurane and Total Intravenous Anesthesia With Propofol and Remifentanil on Early Recovery Quality and Long Term Prognosis of Patients Undergoing Pancreatic Cancer and Common Bile Duct Cancer Surgery

Not Applicable
Conditions
Pancreatic Cancer or Distal CBD Cancer
Interventions
Drug: TIVA (Total intravenous anesthesia with propofol and remifentanil)
Drug: Des (volatile anesthetic-desflurane)
First Posted Date
2018-02-27
Last Posted Date
2019-01-11
Lead Sponsor
Yonsei University
Target Recruit Count
132
Registration Number
NCT03447691
Locations
🇰🇷

Department of Anesthesiology and Pain Medicine Anesthesia and Pain Research Institute Yonsei University College of Medicine, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath